PHASE II STUDY OF IFOSFAMIDE, CARBOPLATIN, AND ETOPOSIDE IN PATIENTS WITH A FIRST RECURRENCE OF GLIOBLASTOMA MULTIFORME

被引：0
作者：
Aoki, T. [1 ]
Ueba, T. [3 ]
Takahashi, J. [1 ]
Miyatake, S. [2 ]
Nozaki, K. [4 ]
Taki, W. [5 ]
Matsutani, M. [6 ]
机构：
[1] Kitano Hosp, Brain Tumor Ctr, Osaka, Japan
[2] Osaka Med Coll, Takatsuki, Osaka 569, Japan
[3] Kishiwada City Hosp, Kishiwada, Japan
[4] Shiga Univ Med Sci, Otsu, Shiga 52021, Japan
[5] Mie Univ, Tsu, Mie 514, Japan
[6] Saitama Med Univ, Int Med Ctr, Saitama, Japan
来源：
NEURO-ONCOLOGY | 2010年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：48 / 48
页数：1
相关论文
共 50 条
  • [41] Treatment of newly diagnosed glioblastoma multiforme with carmustine, cisplatin and etoposide followed by radiotherapy. A phase II study
    Lassen, U
    Kristjansen, PEG
    Wagner, A
    Kostel-janetz, M
    Poulsen, HS
    JOURNAL OF NEURO-ONCOLOGY, 1999, 43 (02) : 161 - 166
  • [42] PHASE-II STUDY OF CARBOPLATIN AND ETOPOSIDE AS A FIRST-LINE REGIMEN IN PATIENTS WITH METASTATIC BREAST-CANCER
    VANDERGAAST, A
    BONTENBAL, M
    PLANTING, AST
    KOK, TC
    SPLINTER, TAW
    ANNALS OF ONCOLOGY, 1994, 5 (09) : 858 - 860
  • [43] A PHASE-I STUDY OF IFOSFAMIDE CARBOPLATIN ETOPOSIDE PACLITAXEL IN ADVANCED LUNG-CANCER
    STRAUSS, GM
    LYNCH, TJ
    ELIAS, AD
    JACOBS, C
    KWIATKOWSKI, DJ
    SHULMAN, LN
    CAREY, RW
    GROSSBARD, ML
    JAUSS, S
    SUGARBAKER, DJ
    SKARIN, AT
    SEMINARS IN ONCOLOGY, 1995, 22 (04) : 70 - 74
  • [44] Oral trofosfamide and etoposide in pediatric patients with glioblastoma multiforme
    Wolff, JEA
    Mölenkamp, G
    Westphal, S
    Pietsch, T
    Gnekow, A
    Kortmann, RD
    Kuehl, J
    CANCER, 2000, 89 (10) : 2131 - 2137
  • [45] Phase II study of CCI-779 in patients with recurrent glioblastoma multiforme
    Susan M. Chang
    Patrick Wen
    Timothy Cloughesy
    Harry Greenberg
    David Schiff
    Charles Conrad
    Karen Fink
    H. Ian Robins
    Lisa De Angelis
    Jeffrey Raizer
    Kenneth Hess
    Ken Aldape
    Kathleen R. Lamborn
    John Kuhn
    Janet Dancey
    Michael D. Prados
    Investigational New Drugs, 2005, 23 : 357 - 361
  • [46] Phase I/II study of dianhydrogalactitol in patients with recurrent malignant glioblastoma multiforme
    Shih, Kent C.
    Patel, Manish R.
    Butowski, Nicholas
    Bacha, Jeffrey A.
    Brown, Dennis M.
    Steino, Anne
    Schwartz, Richard
    Kanekai, Sarath
    Lopez, Lorena M.
    Burris, Howard A.
    CANCER RESEARCH, 2015, 75
  • [47] Phase II study of pembrolizumab plus SurVaxM for glioblastoma at first recurrence.
    Ahluwalia, Manmeet Singh
    Peereboom, David M.
    Ciolfi, Marci
    Schilero, Cathy
    Hobbs, Brian
    Ciesielski, Michael J.
    Fenstermaker, Robert Alan
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [48] A PHASE II TRIAL OF EVEROLIMUS IN PATIENTS WITH RECURRENT GLIOBLASTOMA MULTIFORME
    Cloughesy, Timothy
    Raizer, J.
    Drappatz, J.
    Gerena-Lewis, M.
    Rogerio, J.
    Yacoub, S.
    Desjardin, A.
    NEURO-ONCOLOGY, 2011, 13 : 42 - 43
  • [49] A PHASE II TRIAL OF VANDETANIB FOR PATIENTS WITH RECURRENT GLIOBLASTOMA MULTIFORME
    Kreisl, Teri
    Burman, John A.
    Albert, Paul
    Kim, Lyndon
    Moore, Kraig
    Fine, Howard
    NEURO-ONCOLOGY, 2008, 10 (05) : 827 - 827
  • [50] A phase II study of XL184 in patients (pts) with progressive glioblastoma multiforme (GBM) in first or second relapse
    De Groot, J. F.
    Prados, M.
    Urquhart, T.
    Robertson, S.
    Yaron, Y.
    Sorensen, A. G.
    Norton, A.
    Batchelor, T.
    Drappatz, J.
    Wen, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
12345